Management of hirsutism
- PMID: 24251227
- PMCID: PMC3830374
- DOI: 10.4103/2230-8210.119511
Management of hirsutism
Abstract
Although hirsutism is a frequent and distressing disorder often signaling an underlying endocrine disorder, a systematic approach to evaluation and the use of combination therapy will provide satisfactory treatment for most patients.
Keywords: 17-hydroxyprogesterone; Ferriman Gallwey Score; Hirsutism; PCOD.
Conflict of interest statement
References
-
- Deplewski D, Rosenfield RL. Role of hormones in pilosebaceous unit development. Endocr Rev. 2000;21:363–92. - PubMed
-
- Ferriman D, Gallwey JD. Clinical assessment of body hair growth in women. J Clin Endocrinol Metab. 1961;21:1440–7. - PubMed
-
- Zawadzki JK, Dunaif A. Diagnostic criteria for polycystic ovary syndrome: Towards a rational approach. In: Dunaif A, Givens JR, Haseltine F, Merriam GR, editors. Polycystic ovary syndrome. Boston: Blackwell Scientific Publications; 1990. pp. 377–84.
-
- Pazos F, Escobar-Morreale HF, Balsa J, Sancho JM, Varela C. Prospective randomized study comparing the long-acting gonadotropin-releasing hormone agonist triptorelin, flutamide, and cyproterone acetate, used in combination with an oral contraceptive. in the treatment of hirsutism. Fertil Steril. 1999;71:122–8. - PubMed
-
- Cosma M, Swiglo BA, Flynn DN, Kurtz DM, Labella ML, Mullan RJ, et al. Clinical review: Insulin sensitizers for the treatment of hirsutism: A systematic review and metaanalyses of randomized controlled trials. J Clin Endocrinol Metab. 2008;93:1135–42. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources